Cargando…

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

Mostrar otras versiones (1)

Although mRNA vaccines prevent COVID-19, variants jeopardize their efficacy as immunity wanes. Here, we assessed the immunogenicity and protective activity of historical (mRNA-1273, designed for Wuhan-1 spike) or modified (mRNA-1273.351, designed for B.1.351 spike) preclinical Moderna mRNA vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Baoling, Whitener, Bradley, VanBlargan, Laura A., Hassan, Ahmed O., Shrihari, Swathi, Liang, Chieh-Yu, Karl, Courtney E., Mackin, Samantha, Chen, Rita E., Kafai, Natasha M., Wilks, Samuel H., Smith, Derek J., Carreño, Juan Manuel, Singh, Gagandeep, Krammer, Florian, Carfi, Andrea, Elbashir, Sayda, Edwards, Darin K., Thackray, Larissa B., Diamond, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404887/ https://www.ncbi.nlm.nih.gov/pubmed/34462745 http://dx.doi.org/10.1101/2021.08.25.457693

Ejemplares similares

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
por: Ying, Baoling, et al.
Publicado: (2021)

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
por: Darling, Tamarand L., et al.
Publicado: (2022)

Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice
por: Ying, Baoling, et al.
Publicado: (2022)

Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
por: Ying, Baoling, et al.
Publicado: (2022)

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
por: Scheaffer, Suzanne M., et al.
Publicado: (2022)

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
por: Suryadevara, Naveenchandra, et al.
Publicado: (2021)

Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice
por: Case, James Brett, et al.
Publicado: (2021)

A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis
por: Goo, Leslie, et al.
Publicado: (2017)

Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
por: Case, James Brett, et al.
Publicado: (2021)

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1
por: Narayanan, Elisabeth, et al.
Publicado: (2022)

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections
por: VanBlargan, Laura A., et al.
Publicado: (2018)

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
por: Mackin, Samantha R., et al.
Publicado: (2022)

Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor
por: Basore, Katherine, et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021)

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
por: Diamond, Michael, et al.
Publicado: (2021)

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
por: Hassan, Ahmed O., et al.
Publicado: (2020)

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
por: Hassan, Ahmed O., et al.
Publicado: (2020)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura A., et al.
Publicado: (2022)

prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis
por: A. Dowd, Kimberly, et al.
Publicado: (2023)

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice
por: Walls, Alexandra C., et al.
Publicado: (2022)

Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
por: Garcia-Dominguez, Dario, et al.
Publicado: (2022)

The Type-Specific Neutralizing Antibody Response Elicited by a Dengue Vaccine Candidate Is Focused on Two Amino Acids of the Envelope Protein
por: VanBlargan, Laura A., et al.
Publicado: (2013)

Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis
por: Case, James Brett, et al.
Publicado: (2020)

Helminth–virus interactions: determinants of coinfection outcomes
por: Desai, Pritesh, et al.
Publicado: (2021)

LDLRAD3 is a receptor for Venezuelan equine encephalitis virus
por: Ma, Hongming, et al.
Publicado: (2020)

Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2023)

Entry receptors — the gateway to alphavirus infection
por: Zimmerman, Ofer, et al.
Publicado: (2023)

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice
por: Malonis, Ryan J., et al.
Publicado: (2022)

Ancestral Reconstruction
por: Joy, Jeffrey B., et al.
Publicado: (2016)

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
por: Case, James Brett, et al.
Publicado: (2020)

Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
por: Chen, Rita E., et al.
Publicado: (2021)

Resurrection of an ancestral 5S rRNA
por: Lu, Qing, et al.
Publicado: (2011)

A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
por: VanBlargan, Laura A., et al.
Publicado: (2021)

Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
por: Edwards, Darin K, et al.
Publicado: (2022)

An ancestral molecular response to nanomaterial particulates
por: del Giudice, G., et al.
Publicado: (2023)

Malaria in Children
por: Kafai, Natasha M., et al.
Publicado: (2018)

Ancestral Genomes: a resource for reconstructed ancestral genes and genomes across the tree of life
por: Huang, Xiaosong, et al.
Publicado: (2019)

Resegmentation is an ancestral feature of the gnathostome vertebral skeleton
por: Criswell, Katharine E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ecas46u2j1ct6uh81bs3j10e8k